CLINICAL_TRIALS ClinicalTrials.gov record update

A 12-week, Randomized, Double-blind, Placebo Controlled, Parallel Group Study Evaluating the Efficacy & Safety of Aliskiren in Patients With Diabetes & Hypertension Not Adequately Responsive to the Combination of Valsartan 160 mg & Hydrochlorothiazide 25 mg

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00219102
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:25.166749+00:00
Published At: 2020-02-11T00:00:00+00:00
Record Updated At: 2020-02-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hypertension", "Diabetes"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-02-11"
protocolSection.identificationModule.nctId: "NCT00219102"
protocolSection.identificationModule.officialTitle: "A 12-week, Randomized, Double-blind, Placebo Controlled, Parallel Group Study Evaluating the Efficacy \u0026 Safety of Aliskiren in Patients With Diabetes \u0026 Hypertension Not Adequately Responsive to the Combination of Valsartan 160 mg \u0026 Hydrochlorothiazide 25 mg"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.